Intrexon Corporation (XON)

8.95 -0.11 (-1.214%)

IEX Real-Time Price

12:02:37 PM EST.

Nasdaq Global Select : Healthcare

Prev Close 9.06

Price Open 9.04

Volume: 429,319

Avg Volume: 1.5M

Market Cap: 1.25B

P/E Ratio -12.43

52 Wk Range 8.73-20.16



XON Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
135.6M
32.9M
13.04
24.26%

2018-09-28
135.6M
32.92M
16.36
24.27%

2018-08-31
135.6M
32.61M
34.92
24.05%

2018-08-15
135.62M
31.64M
26.34
23.33%




XON Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-11-08
Q3 2018
AMC
-0.23 (3)
-0.14
0.09

2018-08-09
Q2 2018
AMC
-0.23 (4)
-0.24
-0.01

2018-05-10
Q1 2018
AMC
-0.24 (4)
-0.17
0.07

2018-05-09
Q1 2018
N/A
-0.24 (4)
0.00
0.00

News

Oxitec Transitioning Friendly(TM) Self-limiting Mosquitoes to 2nd Generation Technology Platform, Paving Way to New Scalability, Performance and Cost Breakthroughs (2018-11-28 07:30 PR Newswire)

OXFORD, England , Nov. 28, 2018 /PRNewswire/ -- Oxitec, Ltd, a UK-based biotechnology company that pioneered the use of biologically-engineered insects for control of disease-spreading Aedes aegypti mosquitoes and crop-destroying agricultural pests, announced today it will be transit…

 


Statistics

Shares Outstanding: 139.16M

Top 15 Institution Percent: 108.10

Price To Sales: 6.65

Price To Book: 2.34

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -20.98

Return On Equity: -36.74

Profit Margin: N/A

Price History

Beta: 1.51

50-day Moving Avg: 12.69

200-day Moving Avg: 15.01

YTD Change: -32.74

5-day Change: -7.55

1-month Change: -9.40

3-month Change: -35.79

6-month Change: -46.89

1-year Change: -30.25

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Intrexon Corporation

Exchange: Nasdaq Global Select

Industry: Biotechnology

Sector: Healthcare

Website: http://www.dna.com

Intrexon Corp is a biotechnology company that develops synthetic biology solutions. It designs, builds and regulates gene programs using its proprietary and complementary technologies.